Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,702
Closed -$361K 450
2025
Q3
$361K Sell
2,702
-928
-26% -$113K 0.03% 443
2025
Q2
$451K Sell
3,630
-648
-15% -$82.5K 0.03% 429
2025
Q1
$544K Sell
4,278
-176
-4% -$27.1K 0.03% 406
2024
Q4
$641K Sell
4,454
-130
-3% -$18.6K 0.04% 351
2024
Q3
$682K Sell
4,584
-318
-6% -$45.6K 0.04% 342
2024
Q2
$618K Buy
4,902
+756
+18% +$118K 0.04% 379
2024
Q1
$763K Sell
4,146
-55
-1% -$10.5K 0.05% 309
2023
Q4
$755K Sell
4,201
-71
-2% -$11.1K 0.06% 289
2023
Q3
$679K Sell
4,272
-25
-0.6% -$4.09K 0.06% 286
2023
Q2
$608K Buy
4,297
+22
+0.5% +$3.53K 0.05% 301
2023
Q1
$720K Buy
4,275
+12
+0.3% +$2.14K 0.07% 263
2022
Q4
$722K Sell
4,263
-290
-6% -$52.6K 0.07% 239
2022
Q3
$852K Buy
4,553
+25
+0.6% +$5.27K 0.09% 203
2022
Q2
$735K Buy
4,528
+43
+1% +$6.8K 0.08% 219
2022
Q1
$844K Buy
4,485
+62
+1% +$11.8K 0.07% 230
2021
Q4
$1.17M Sell
4,423
-50
-1% -$13.5K 0.08% 191
2021
Q3
$1.29M Sell
4,473
-166
-4% -$42.6K 0.09% 166
2021
Q2
$926K Sell
4,639
-84
-2% -$16.3K 0.06% 210
2021
Q1
$919K Buy
4,723
+83
+2% +$17K 0.07% 205
2020
Q4
$889K Buy
4,640
+9
+0.2% +$1.64K 0.07% 199
2020
Q3
$684K Sell
4,631
-60
-1% -$8.58K 0.06% 206
2020
Q2
$580K Sell
4,691
-470
-9% -$55.3K 0.06% 205
2020
Q1
$498K Buy
5,161
+489
+10% +$47.2K 0.06% 202
2019
Q4
$433K Buy
4,672
+750
+19% +$63K 0.04% 283
2019
Q3
$301K Buy
3,922
+153
+4% +$13.4K 0.03% 379
2019
Q2
$324K Buy
3,769
+245
+7% +$16.7K 0.03% 358
2019
Q1
$209K Buy
+3,524
New +$203K 0.02% 475

Other funds holding RGEN

Pitcairn's RGEN Position: Q4 2025 in Review

Pitcairn sold out of Repligen (RGEN) in Q4 2025, closing a stake of 2,702 shares — an estimated $361K sold.

Pitcairn first reported a position in RGEN in Q1 2019 and held it in 27 quarters. The position peaked at $1.29M in Q3 2021. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Pitcairn reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 2,702 Repligen shares in Q4 2025, an estimated $361K.
  • Pitcairn first reported a position in Repligen in Q1 2019 and held it in 27 quarters.
  • Pitcairn's Repligen position peaked at $1.29M in Q3 2021.
  • 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.